WOBURN, Mass., July 26 /PRNewswire/ -- SRU Biosystems announced today that U.S. Patent 7,074,311 (the '311 patent), entitled "Biosensor Electrophoresis" was issued to SRU Biosystems, Inc. on July 11, 2006. "The '311 patent demonstrates the flexibility and breadth of the BIND(TM) technology," stated SRU Biosystems' President & CEO Owen Dempsey, "which allows us to take label-free detection into all areas of life science research. SRU's intellectual property portfolio encompasses all aspects of SRU's BIND(TM) system, which continues to set the standards in label-free detection."
About SRU Biosystems
SRU Biosystems, Inc., is a life science company developing novel technologies for rapidly analyzing the interactions of large genomic, protein, peptide, antibody or small molecule compound libraries against a wide range of biochemical targets. SRU is incorporating its technology into microtiter plates, microarray slides and other industry standard formats to create sensitive and high throughput tools that can be used to answer important biological questions for biomedical research, pharmaceutical drug discovery and diagnostics.
For more information, please contact: Brant Binder, CFO Bbinder@srubiosystems.com +1 781-933-7255, ext. 202
SRU Biosystems, Inc.CONTACT: Brant Binder, CFO of SRU Biosystems, Inc., +1-781-933-7255, Ext.202, Bbinder@srubiosystems.com
Web site: http://www.srubiosystems.com//
